NAPROXEN
- Product NDC
- 61919-162
- 11-digit product format
- 619190162
- Labeler code
- 61919
- Product ID
- 61919-162_f202b8ea-9615-7a4b-e053-2a95a90a008d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA078250
- Marketing category
- ANDA
- Marketing start
- 2016-08-29
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 375 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-162-30 | NAPROXEN | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
| 61919-162-60 | NAPROXEN | 60 in 1 BOTTLE | TABLET | 60 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-162 | NAPROXEN TABLET [DIRECT RX] | 5 | Legacy NDC, 2 package rows | 20230413_3b36a761-64dc-673f-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-162-30 | 61919016230 | 30 TABLET in 1 BOTTLE (61919-162-30) | 30 tablet | 2016-08-29 | 0000-00-00 | No | No | Current |
| 61919-162-60 | 61919016260 | 60 TABLET in 1 BOTTLE (61919-162-60) | 60 tablet | 2016-08-29 | 0000-00-00 | No | No | Current |